On Demand: ERS 2021 – Australian context, international perspectives

A panel of Australian and international experts present their highlights from the ERS International Congress. They also discuss the challenges facing clinicians dealing with the current COVID situation here in Australia. Watch now on-demand: ...

A panel of Australian and international experts present their highlights from the ERS International Congress. They also discuss the challenges...

News in brief: Airborne health advisor in TIME magazine’s 100 most influential people; CFTR modulators may improve CF liver disease; Telehealth MBS items now available for hospital inpatients

Airborne health advisor in TIME magazine's 100 most influential people An Australian expert on air quality and health, Distinguished Professor Lidia Morawska, has been named in the 2021 TIME100 list of the...

Airborne health advisor in TIME magazine's 100 most influential people An Australian...

COPD

Interventional bronchoscopy deserves wider use in COPD: Australian experts

Endoscopic lung volume reduction (ELVR) for advanced COPD that is refractory to standard care has been associated with significant improvements in lung function and exercise capacity - yet the procedure is rarely offered in Australia despite support of its use...

Endoscopic lung volume reduction (ELVR) for advanced COPD that is refractory to standard care has been associated with significant improvements...

Lung cancer

Adjuvant immunotherapy the new standard of care in patients with resected, early-stage NSCLC?

Patients with resected, early-stage non-small cell lung cancer (NSCLC) may benefit from adjuvant immunotherapy following adjuvant chemotherapy, according to new findings from a trial of atezolizumab. Presented at the European Society for Medical Oncology (ESMO) virtual Congress 2021, the results from the...

Patients with resected, early-stage non-small cell lung cancer (NSCLC) may benefit from adjuvant immunotherapy following adjuvant chemotherapy, according to new...